DNA methylation status as a biomarker of anti‐epidermal growth factor receptor treatment for metastatic colorectal cancer

Anti‐epidermal growth factor receptor (EGFR) treatment is an effective option for metastatic colorectal cancer (CRC) treatment. However, there are few reliable biomarkers to predict the clinical response to anti‐EGFR treatment. We investigated the genome‐wide DNA methylation status in metastatic col...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouchi, Kota, Takahashi, Shin, Yamada, Yasuhide, Tsuji, Shingo, Tatsuno, Kenji, Takahashi, Hidekazu, Takahashi, Naoki, Takahashi, Masanobu, Shimodaira, Hideki, Aburatani, Hiroyuki, Ishioka, Chikashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714671/
https://www.ncbi.nlm.nih.gov/pubmed/26426205
http://dx.doi.org/10.1111/cas.12827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714671/
https://www.ncbi.nlm.nih.gov/pubmed/26426205
http://dx.doi.org/10.1111/cas.12827

Ejemplares similares